These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3366764)

  • 1. Methotrexate-resistant Leishmania donovani genetically deficient in the folate-methotrexate transporter.
    Kaur K; Coons T; Emmett K; Ullman B
    J Biol Chem; 1988 May; 263(15):7020-8. PubMed ID: 3366764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional requirements of wild-type and folate transport-deficient Leishmania donovani for pterins and folates.
    Beck JT; Ullman B
    Mol Biochem Parasitol; 1990 Dec; 43(2):221-30. PubMed ID: 2090944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopterin conversion to reduced folates by Leishmania donovani promastigotes.
    Beck JT; Ullman B
    Mol Biochem Parasitol; 1991 Nov; 49(1):21-8. PubMed ID: 1775157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity labeling of the folate-methotrexate transporter from Leishmania donovani.
    Beck JT; Ullman B
    Biochemistry; 1989 Aug; 28(17):6931-7. PubMed ID: 2554960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in methotrexate and folate influx in methotrexate-resistant lines of Leishmania major are independent of R or H region amplification.
    Ellenberger TE; Beverley SM
    J Biol Chem; 1987 Oct; 262(28):13501-6. PubMed ID: 3654626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major.
    Nare B; Hardy LW; Beverley SM
    J Biol Chem; 1997 May; 272(21):13883-91. PubMed ID: 9153248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a mutant clone of Leishmania donovani deficient in folate transport.
    Beck J; Ullman B
    Adv Exp Med Biol; 1989; 253B():533-8. PubMed ID: 2610143
    [No Abstract]   [Full Text] [Related]  

  • 8. Inactivation of the Leishmania tarentolae pterin transporter (BT1) and reductase (PTR1) genes leads to viable parasites with changes in folate metabolism and hypersensitivity to the antifolate methotrexate.
    El Fadili A; Kündig C; Roy G; Ouellette M
    J Biol Chem; 2004 Apr; 279(18):18575-82. PubMed ID: 14981076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae.
    Kündig C; Haimeur A; Légaré D; Papadopoulou B; Ouellette M
    EMBO J; 1999 May; 18(9):2342-51. PubMed ID: 10228149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new type of high affinity folic acid transporter in the protozoan parasite Leishmania and deletion of its gene in methotrexate-resistant cells.
    Richard D; Kündig C; Ouellette M
    J Biol Chem; 2002 Aug; 277(33):29460-7. PubMed ID: 12023977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of folate receptor expression following stable transfection into wild type and methotrexate transport-deficient ZR-75-1 human breast cancer cells.
    Dixon KH; Mulligan T; Chung KN; Elwood PC; Cowan KH
    J Biol Chem; 1992 Nov; 267(33):24140-7. PubMed ID: 1429743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
    Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
    J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
    Dixon KH; Trepel JB; Eng SC; Cowan KH
    Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type and drug-resistant Leishmania major hydrolyze methotrexate to N-10-methyl-4-deoxy-4-aminopteroate without accumulation of methotrexate polyglutamates.
    Ellenberger TE; Wright JE; Rosowsky A; Beverley SM
    J Biol Chem; 1989 Sep; 264(27):15960-6. PubMed ID: 2476435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
    Nare B; Luba J; Hardy LW; Beverley S
    Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells.
    Henderson GB; Strauss BP
    Cancer Res; 1990 Mar; 50(6):1709-14. PubMed ID: 2306724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polyglutamylation of methotrexate on its accumulation and the development of resistance in the protozoan parasite Leishmania.
    El-Fadili A; Richard D; Kündig C; Ouellette M
    Biochem Pharmacol; 2003 Sep; 66(6):999-1008. PubMed ID: 12963486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogues.
    Stone SR; Montgomery JA; Morrison JF
    Biochem Pharmacol; 1984 Jan; 33(2):175-9. PubMed ID: 6367748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
    Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
    Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.